 |
David V. Goeddel, Ph.D.
|
Executive Chairman
|
| John K. Celebi, MBA |
Chief Business Officer |
| Guoqing Chen, Ph.D. |
VP of Research |
| Paul W. Sauer, MBA |
VP of Process Development |
 |
David V. Goeddel, Ph.D.
|
Executive Chairman |
| John D. Diekman, Ph.D. |
| Carl L. Gordon, Ph.D., CFA |
| Robert Schreiber, Ph.D. |
 |
Robert Schreiber, Ph.D.
|
Chairman |
| Rudolf Aebersold, Ph.D. |
|
| Frederick Appelbaum, M.D. |
|
| Thomas Kipps, M.D., Ph.D. |
|
| Richard Klausner, M.D. |
|
| Jeffrey V. Ravetch, M.D., Ph.D. |
|
| Richard Ulevitch, Ph.D. |
|
| Emil Unanue, M.D. |
|
| |
| |
| |
|
|
 |
Dr. Appelbaum is Director of Clinical Research Division of Fred Hutchinson Cancer Center. He joined Fred Hutchinson Cancer Research Center's (FHCRC) scientific staff in 1978, and in 1988 became a Full Member of the Hutchinson Center faculty as well as a Professor of Medicine, Division of Oncology, at the UW. Dr. Appelbaum has been Senior Vice President and Director of the Clinical Research Division at FHCRC since 1993 and was named Executive Director of SCCA and Head of the Division of Medical Oncology at the UW School of Medicine in 1998. He is the author of over 800 scientific articles and was the lead author on the first paper to describe the successful use of autologous marrow transplantation. Dr. Applebaum's current areas of research interests center on the biology and treatment of hematologic malignancies. |
|